Abound Wealth Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.95K Sell
76
-234
-75% -$20.5K ﹤0.01% 539
2026
Q1
$26.4K Buy
310
+131
+73% +$11.7K 0.01% 342
2025
Q4
$14.2K Buy
179
+31
+21% +$2.43K ﹤0.01% 439
2025
Q3
$11.9K Buy
148
+3
+2% +$256 ﹤0.01% 458
2025
Q2
$13.2K Sell
145
-34
-19% -$3.1K ﹤0.01% 395
2025
Q1
$16.8K Buy
179
+2
+1% +$179 0.01% 323
2024
Q4
$16.1K Buy
177
+12
+7% +$1.15K 0.01% 317
2024
Q3
$17.2K Hold
165
0.01% 322
2024
Q2
$16K Buy
165
+2
+1% +$184 0.01% 293
2024
Q1
$14.7K Sell
163
-140
-46% -$11.9K 0.01% 307
2023
Q4
$24.2K Buy
303
+101
+50% +$7.59K 0.01% 228
2023
Q3
$14.4K Buy
202
+4
+2% +$299 0.01% 272
2023
Q2
$15.3K Buy
198
+101
+104% +$7.82K 0.01% 266
2023
Q1
$7.31K Buy
97
+3
+3% +$223 ﹤0.01% 331
2022
Q4
$7.42K Buy
94
+57
+154% +$4.27K ﹤0.01% 298
2022
Q3
$2.62K Buy
+37
New +$2.9K ﹤0.01% 447

Other funds holding CL

Abound Wealth Management's CL Position: Q2 2026 in Review

Abound Wealth Management reduced its Colgate-Palmolive (CL) stake by 75% in Q2 2026, selling an estimated $20.5K and leaving 76 shares worth $6.95K. The position accounts for ﹤0.01% of the portfolio, ranked #539.

Abound Wealth Management first reported a position in CL in Q3 2022 and has held it in 16 quarters since. The position peaked at $26.4K in Q1 2026. 658 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Abound Wealth Management held 76 shares of Colgate-Palmolive worth $6.95K as of Q2 2026.
  • Abound Wealth Management sold 234 Colgate-Palmolive shares in Q2 2026, an estimated $20.5K.
  • Colgate-Palmolive made up ﹤0.01% of Abound Wealth Management's portfolio in Q2 2026, its #539 holding.
  • Abound Wealth Management first reported a position in Colgate-Palmolive in Q3 2022 and has held it in 16 quarters since.
  • Abound Wealth Management's Colgate-Palmolive position peaked at $26.4K in Q1 2026.
  • 658 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Abound Wealth Management's 13F filing for Q2 2026, filed 10 Jul 2026.